Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
Shafran
S D
SD
D017088:AIDS-Related Opportunistic Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D017291:Clarithromycin / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D015269:Mycobacterium avium Complex / Q000187:drug effects / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D015996:Survival Rate
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D017291:Clarithromycin